Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. [electronic resource]
Producer: 20131022Description: 559-70 p. digitalISSN:- 1550-7416
- Adolescent
- Adult
- Aged
- Anti-Asthmatic Agents -- administration & dosage
- Antibodies, Anti-Idiotypic -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Asthma -- diagnosis
- Biomarkers -- blood
- Breath Tests
- Child
- Computer Simulation
- Double-Blind Method
- Drug Administration Schedule
- Female
- Forced Expiratory Volume
- Humans
- Immunoglobulin E -- blood
- Lung -- drug effects
- Male
- Middle Aged
- Models, Biological
- Monte Carlo Method
- Nitric Oxide -- metabolism
- Omalizumab
- Prospective Studies
- Spirometry
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.